Lysosomal Storage Disorders: Molecular Basis and Therapeutic Approaches
Lysosomal storage disorders are a heterogenoeus group of rare genetic conditions affecting worldwide population and often exhibiting severe clinical manifestations. During the last two decades, the joined collaboration between scientists and clinicians has allowed to offer valuable therapeutic optio...
Saved in:
| Sonstige: | |
|---|---|
| Year of Publication: | 2021 |
| Language: | English |
| Physical Description: | 1 electronic resource (301 p.) |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| id |
993546364304498 |
|---|---|
| ctrlnum |
(CKB)5400000000044152 (oapen)https://directory.doabooks.org/handle/20.500.12854/76883 (EXLCZ)995400000000044152 |
| collection |
bib_alma |
| record_format |
marc |
| spelling |
Moro, Enrico edt Lysosomal Storage Disorders: Molecular Basis and Therapeutic Approaches Lysosomal Storage Disorders Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2021 1 electronic resource (301 p.) text txt rdacontent computer c rdamedia online resource cr rdacarrier Lysosomal storage disorders are a heterogenoeus group of rare genetic conditions affecting worldwide population and often exhibiting severe clinical manifestations. During the last two decades, the joined collaboration between scientists and clinicians has allowed to offer valuable therapeutic options to affected patients. Therefore, the tight connection between basic science and clinical medicine represents the gold standard approach to these disorders. In this context, the present book collects a piece of current scientific advances in the knowledge of disease pathogenesis and in the development of novel diagnostic and therapeutic strategies for some of these diseases. Altogether, these articles define and recapitulate which essential steps are required during the clinical management of a rare inherited disorder and describe forthcoming advances and a breakthrough in the field of lysosomal diseases. English Medicine bicssc mucopolysaccharidosis IIIB quantitative proteomics NAGLU lysosomes Gaucher disease bone involvement enzyme replacement therapy substrate reduction therapy Osteoimmunology RANK/RANKL Osteopontin MIP-1β mucolipidosis II sortilin TGF-beta cathepsin D Fabry disease alpha-galactosidase A endocytosis lysosome IGF2R/M6P clathrin chloroquine lysosomal diseases precision medicine pharmacological chaperones gene therapy. Pompe disease lysosomal targeting autophagy gene therapy muscle satellite cells rhGAA glycogen lysosomal α-glucosidase GAA biomarker Gaucher Disease Wnt/β-catenin Dkk1 Wnt3a iPSC neuronopathy Krabbe disease Twitcher mouse psychosine visual system visual cortex astrogliosis mucopolysaccharidosis type I Hurler syndrome hematopoietic stem cell transplantations animal models experimental therapies axon guidance lysosomal storage disorders neuronal circuit α-galactosidase A A4GALT globotriaosylceramide (Gb3) globotriaosyl-sphingosine (lysoGb3) pharmacological chaperone therapy exosomes endocytic pathways neurodegenerative disease Parkinson disease lysosomal storage disorder viral vectors newborn screening variant interpretation second tier test tandem mass spectrometry lyso-Gb3 dried blood spot GLA gene globotriaosylsphingosine biomarkers 3-0365-1967-X 3-0365-1966-1 Moro, Enrico oth |
| language |
English |
| format |
eBook |
| author2 |
Moro, Enrico |
| author_facet |
Moro, Enrico |
| author2_variant |
e m em |
| author2_role |
Sonstige |
| title |
Lysosomal Storage Disorders: Molecular Basis and Therapeutic Approaches |
| spellingShingle |
Lysosomal Storage Disorders: Molecular Basis and Therapeutic Approaches |
| title_full |
Lysosomal Storage Disorders: Molecular Basis and Therapeutic Approaches |
| title_fullStr |
Lysosomal Storage Disorders: Molecular Basis and Therapeutic Approaches |
| title_full_unstemmed |
Lysosomal Storage Disorders: Molecular Basis and Therapeutic Approaches |
| title_auth |
Lysosomal Storage Disorders: Molecular Basis and Therapeutic Approaches |
| title_alt |
Lysosomal Storage Disorders |
| title_new |
Lysosomal Storage Disorders: Molecular Basis and Therapeutic Approaches |
| title_sort |
lysosomal storage disorders: molecular basis and therapeutic approaches |
| publisher |
MDPI - Multidisciplinary Digital Publishing Institute |
| publishDate |
2021 |
| physical |
1 electronic resource (301 p.) |
| isbn |
3-0365-1967-X 3-0365-1966-1 |
| illustrated |
Not Illustrated |
| work_keys_str_mv |
AT moroenrico lysosomalstoragedisordersmolecularbasisandtherapeuticapproaches AT moroenrico lysosomalstoragedisorders |
| status_str |
n |
| ids_txt_mv |
(CKB)5400000000044152 (oapen)https://directory.doabooks.org/handle/20.500.12854/76883 (EXLCZ)995400000000044152 |
| carrierType_str_mv |
cr |
| is_hierarchy_title |
Lysosomal Storage Disorders: Molecular Basis and Therapeutic Approaches |
| author2_original_writing_str_mv |
noLinkedField |
| _version_ |
1796649052981428225 |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04392nam-a2201225z--4500</leader><controlfield tag="001">993546364304498</controlfield><controlfield tag="005">20231214133615.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202201s2021 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5400000000044152</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/76883</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995400000000044152</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Moro, Enrico</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Lysosomal Storage Disorders: Molecular Basis and Therapeutic Approaches</subfield></datafield><datafield tag="246" ind1=" " ind2=" "><subfield code="a">Lysosomal Storage Disorders</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Basel, Switzerland</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute</subfield><subfield code="c">2021</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (301 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Lysosomal storage disorders are a heterogenoeus group of rare genetic conditions affecting worldwide population and often exhibiting severe clinical manifestations. During the last two decades, the joined collaboration between scientists and clinicians has allowed to offer valuable therapeutic options to affected patients. Therefore, the tight connection between basic science and clinical medicine represents the gold standard approach to these disorders. In this context, the present book collects a piece of current scientific advances in the knowledge of disease pathogenesis and in the development of novel diagnostic and therapeutic strategies for some of these diseases. Altogether, these articles define and recapitulate which essential steps are required during the clinical management of a rare inherited disorder and describe forthcoming advances and a breakthrough in the field of lysosomal diseases.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Medicine</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">mucopolysaccharidosis IIIB</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">quantitative proteomics</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">NAGLU</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lysosomes</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Gaucher disease</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">bone involvement</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">enzyme replacement therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">substrate reduction therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Osteoimmunology</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">RANK/RANKL</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Osteopontin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">MIP-1β</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">mucolipidosis II</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">sortilin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">TGF-beta</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cathepsin D</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Fabry disease</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">alpha-galactosidase A</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">endocytosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lysosome</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">IGF2R/M6P</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">clathrin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">chloroquine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lysosomal diseases</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">precision medicine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pharmacological chaperones</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">gene therapy.</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Pompe disease</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lysosomal targeting</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">autophagy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">gene therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">muscle</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">satellite cells</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">rhGAA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">glycogen</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lysosomal α-glucosidase</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">GAA biomarker</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Gaucher Disease</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Wnt/β-catenin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Dkk1</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Wnt3a</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">iPSC</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">neuronopathy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Krabbe disease</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Twitcher mouse</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">psychosine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">visual system</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">visual cortex</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">astrogliosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">mucopolysaccharidosis type I</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Hurler syndrome</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hematopoietic stem cell transplantations</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">animal models</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">experimental therapies</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">axon guidance</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lysosomal storage disorders</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">neuronal circuit</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">α-galactosidase A</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">A4GALT</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">globotriaosylceramide (Gb3)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">globotriaosyl-sphingosine (lysoGb3)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pharmacological chaperone therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">exosomes</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">endocytic pathways</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">neurodegenerative disease</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Parkinson disease</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lysosomal storage disorder</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">viral vectors</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">newborn screening</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">variant interpretation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">second tier test</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tandem mass spectrometry</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lyso-Gb3</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">dried blood spot</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">GLA gene</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">globotriaosylsphingosine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">biomarkers</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-1967-X</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-1966-1</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Moro, Enrico</subfield><subfield code="4">oth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:59:09 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-04-04 09:22:53 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338221850004498&Force_direct=true</subfield><subfield code="Z">5338221850004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338221850004498</subfield></datafield></record></collection> |